To be a world leader in liquid biopsy and artificial intelligence for early detection of cancer and other diseases.
ClinSpec Dx™ are an award winning team, dedicated to translating this novel technology into the clinic.
Founded in 2016, ClinSpec Dx™ are the spinout company from the University of Strathclyde based upon world leading research.
The team have secured over £2m of funding and continue to advance towards the clinic.
WE BELIEVE THAT
EVERY DAY COUNTS
FOR HEALTH SERVICES
ClinSpec Dx™ are currently raising their second round of funding.
For more information, please contact us or see our page for investors.